{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T05:25:13Z","timestamp":1740029113577,"version":"3.37.3"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1124\/jpet.111.182857","type":"journal-article","created":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T01:44:22Z","timestamp":1309484662000},"page":"186-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Influence of Tissue Integrity on Pharmacological Phenotypes of Muscarinic Acetylcholine Receptors in the Rat Cerebral Cortex"],"prefix":"10.1016","volume":"339","author":[{"given":"Abu Syed","family":"Md Anisuzzaman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Nishimune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatsumi","family":"Yoshiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junsuke","family":"Uwada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikunobu","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.111.182857_bib1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/sj.bjp.0706780","article-title":"Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder","volume":"148","author":"Abrams","year":"2006","journal-title":"Br J Pharmacol"},{"issue":"Suppl 1","key":"10.1124\/jpet.111.182857_bib2","first-page":"S1","article-title":"Guide to Receptors and Channels (GRAC), 4th Edition","volume":"158","author":"Alexander","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.111.182857_bib3","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejphar.2008.10.008","article-title":"Identification of M1 muscarinic receptor subtype in rat stomach using a tissue segment binding method, and the effects of immobilization stress on the muscarinic receptors","volume":"599","author":"Anisuzzaman","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.111.182857_bib4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1254\/jphs.FP0071435","article-title":"Assessment of muscarinic receptor subtypes in human and rat lower urinary tract by tissue segment binding assay","volume":"106","author":"Anisuzzaman","year":"2008","journal-title":"J Pharmacol Sci"},{"key":"10.1124\/jpet.111.182857_bib5","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.tips.2007.06.011","article-title":"Multiple GPCR conformations and signaling pathways: implications for antagonist affinity estimates","volume":"28","author":"Baker","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.111.182857_bib6","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1476-5381.1985.tb10566.x","article-title":"Solubilization and characterization of high and low affinity pirenzepine binding sites from rat cerebral cortex","volume":"85","author":"Berrie","year":"1985","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.111.182857_bib7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.pharmthera.2004.06.004","article-title":"GPCR interacting proteins (GIP)","volume":"103","author":"Bockaert","year":"2004","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.111.182857_bib8","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1038\/sj.bjp.0702002","article-title":"Characterization of an atypical muscarinic cholinoceptor mediating contraction of the guinea-pig isolated uterus","volume":"124","author":"Boxall","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.111.182857_bib9","doi-asserted-by":"crossref","first-page":"L421","DOI":"10.1152\/ajplung.1993.265.5.L421","article-title":"Radioligand binding methods: practical guide and tips","volume":"265","author":"Bylund","year":"1993","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1124\/jpet.111.182857_bib10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0031-6997(24)01362-0","article-title":"International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors","volume":"50","author":"Caulfield","year":"1998","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.111.182857_bib11","series-title":"Current Protocols in Pharmacology","article-title":"Quantification of allosteric interactions at G-protein coupled receptors using radioligand binding assays","author":"Christopoulos","year":"2000"},{"key":"10.1124\/jpet.111.182857_bib12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/pr.54.2.323","article-title":"G protein-coupled receptor allosterism and complexing","volume":"54","author":"Christopoulos","year":"2002","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.111.182857_bib13","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/287548a0","article-title":"Pharmacological specificity of brain histamine H2-receptors differs in intact cells and cell-free preparations","volume":"287","author":"Dam Trung Tuong","year":"1980","journal-title":"Nature"},{"key":"10.1124\/jpet.111.182857_bib14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1476-5381.1989.tb11838.x","article-title":"Affinity of muscarinic receptor antagonists for three putative muscarinic receptor binding sites","volume":"96","author":"Delmendo","year":"1989","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.111.182857_bib15","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0022-3565(25)23208-6","article-title":"Antagonist binding profiles of five cloned human muscarinic receptor subtypes","volume":"256","author":"D\u00f6rje","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.111.182857_bib16","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0022-3565(25)23162-7","article-title":"Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain","volume":"255","author":"Ehlert","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.111.182857_bib17","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/S0026-895X(25)09847-5","article-title":"Selective labeling and localization of the M4 (m4) muscarinic receptor subtype","volume":"46","author":"Ferrari-Dileo","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.111.182857_bib18","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1146\/annurev.pa.30.040190.003221","article-title":"Muscarinic receptor subtypes","volume":"30","author":"Hulme","year":"1990","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/jpet.111.182857_bib19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nrd1110","article-title":"Predicting therapeutic value in the lead optimization phase of drug discovery","volume":"2","author":"Kenakin","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.111.182857_bib20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0006-2952(95)00137-O","article-title":"On the importance of the \u201cantagonist assumption\u201d to how receptors express themselves","volume":"50","author":"Kenakin","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.111.182857_bib21","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0026-895X(24)12084-6","article-title":"Quantitation of mRNAs for M1 to M5 subtypes of muscarinic receptors in rat heart and brain cortex","volume":"61","author":"Krejc\u00ed","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.111.182857_bib22","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1523\/JNEUROSCI.11-10-03218.1991","article-title":"Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies","volume":"11","author":"Levey","year":"1991","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.111.182857_bib23","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1038\/sj.bjp.0707679","article-title":"Identification of \u03b11L-adrenceptor in rat cerebral cortex and possible relationship between \u03b11L- and \u03b11A-adrenocpetors","volume":"153","author":"Morishima","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.111.182857_bib24","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/sj.bjp.0701794","article-title":"Pharmacological characterization of muscarinic receptors in the uterus of oestrogen-primed and pregnant rats","volume":"123","author":"Munns","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.111.182857_bib25","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/bjp.2008.360","article-title":"Identification of \u03b11L-adrenoceptor in mice and its abolition by \u03b11A-adrenoceptor gene knockout","volume":"155","author":"Muramatsu","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.111.182857_bib26","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1476-5381.2009.00254.x","article-title":"Expression of distinct \u03b11-adrenoceptor phenotypes in the iris of pigmented and albino rabbits","volume":"158","author":"Muramatsu","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.111.182857_bib27","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1254\/jphs.CPJ05001X","article-title":"Quantifying receptor properties: the tissue segment binding method - a powerful tool for the pharmacome analysis of native receptors","volume":"98","author":"Muramatsu","year":"2005","journal-title":"J Pharmacol Sci"},{"key":"10.1124\/jpet.111.182857_bib28","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bcp.2006.09.005","article-title":"\u201cPhenotypic\u201d pharmacology: the influence of cellular environment on G protein-coupled receptor antagonist and inverse agonist pharmacology","volume":"73","author":"Nelson","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.111.182857_bib29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1254\/jphs.10093FP","article-title":"Identification of cysteine-rich epidermal growth factor-like domain 1\u03b1 (CRELD1\u03b1) as a novel \u03b11A-adrenoceptor-down-regulating protein and establishment of an \u03b11L-adrenoceptor-expressing cell line","volume":"113","author":"Nishimune","year":"2010","journal-title":"J Pharmacol Sci"},{"key":"10.1124\/jpet.111.182857_bib30","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1124\/mol.109.055509","article-title":"Agonist-biased signaling via proteinase activated receptor-2: differential activation of calcium and mitogen-activated protein kinase pathways","volume":"76","author":"Ramachandran","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.111.182857_bib31","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejphar.2008.02.003","article-title":"Different affinities of native \u03b11B-adrenoceptors for ketanserin between intact tissue segments and membrane preparations","volume":"584","author":"Sathi","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.111.182857_bib32","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/bjp.2008.318","article-title":"Native profiles of \u03b11A-adrenoceptor phenotypes in rabbit prostate","volume":"155","author":"Su","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.111.182857_bib33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0163-7258(03)00032-9","article-title":"Regulation of muscarinic acetylcholine receptor signaling","volume":"98","author":"van Koppen","year":"2003","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.111.182857_bib34","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0026-895X(25)09445-3","article-title":"Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain","volume":"38","author":"Waelbroeck","year":"1990","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.111.182857_bib35","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrd2379","article-title":"Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development","volume":"6","author":"Wess","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.111.182857_bib36","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1254\/jphs.09147FP","article-title":"Evaluation of \u03b21L-adrenoceptors in rabbit heart by tissue segment binding assay","volume":"110","author":"Yoshiki","year":"2009","journal-title":"J Pharmacol Sci"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524465750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524465750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.111.182857","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T02:36:21Z","timestamp":1740018981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524465750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0022356524465750"],"URL":"https:\/\/doi.org\/10.1124\/jpet.111.182857","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of Tissue Integrity on Pharmacological Phenotypes of Muscarinic Acetylcholine Receptors in the Rat Cerebral Cortex","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.111.182857","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}